Comparison of Animal Serum-Free Media Culture for cGMP-Compliant Mesenchymal Stem Cell Expansion
Abstract
Background: Mesenchymal stem cells (MSCs) are multipotent stromal cells distinguished by their ability to self-renew, their potential for multilineage differentiation, and their strong immunomodulatory characteristics. The recent in vitro expansion of MSCs primarily relies on culture media that is supplemented with fetal bovine serum (FBS). Although FBS is effective in enhancing the proliferation of MSCs and ensuring their survival, its use poses several notable challenges, particularly in clinical environments. Methods: This study seeks to fill this important gap by conducting a comprehensive comparison of various commercially available animal source-serum free media formulations against traditional FBS-supplemented media for the expansion of umbilical cord-derived mesenchymal stem cells (UC-MSCs). The morphology and density of the cells were examined using an inverted microscope. The cell surface of UC-MSCs was analysed through flow cytometry. The evaluation of cytokines released by UC-MSCs was carried out using ELISA. Result: The conditioned medium obtained from UC-MSCs cultured in HPL shows increased levels of exosomes and anti-inflammatory cytokines. Moreover, the UC-MSCs cultured in HPL-supplemented medium maintained a normal morphology and exhibited expression of UC-MSC surface markers exceeding 95%. Additionally, HPL enhanced the proliferation of UC-MSCs to eight times the cell number on the day of seeding. Conclusion: Media enriched with HPL presents considerable potential for future applications within the pharmaceutical sector.
References
Fiolin J, Dilogo IH. Role of mesenchymal stem cell-conditioned medium (MSC-CM) in the bone regeneration: A systematic review from 2007-2018. Annu Res Rev Biol. 2019:1-16.
Han X, Liao R, Li X. Mesenchymal stem cells in treating human diseases: Molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025;10(1):262.
Jayaraman P, Lim R, Ng J, Vemuri MC. Acceleration of translational mesenchymal stromal cell therapy through consistent quality GMP manufacturing. Front Cell Dev Biol. 2021;9:648472.
Zhu W, Huang L, Li Y. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012;315(1):28-37.
Karnieli O, Friedner OM, Allickson JG. A consensus introduction to serum replacements and serum-free media for cellular therapies. Cytotherapy. 2017;19(2):155-169.
Mantripragada VP, Muschle GF. Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media. Curr Res Transl Med. 2022;70.
Thery C, Witwer KW, Aikawa E. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
Li W, Liu Q, Shi J. The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. Front Immunol. 2023;14:1074863.
Kerkis I, da Silva AP, Araldi RP. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions. Front Immunol. 2024;15:1400533.
Li X, Zhang D, Yu Y, Wang L, Zhao M. Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Cell Prolif. 2024;57(4):e13586.
Kahrizi MS, Mousavi E, Khosravi A. Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies. Stem Cell Res Ther. 2023;14(1):155.
Ling L, Hou J, Liu D. Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI). Stem Cell Res Ther. 2022;13(1):79.
Williams ME, Banche Niclot F, Rota S. Optimizing mesenchymal stem cell therapy: From isolation to GMP-compliant expansion for clinical application. BMC Mol Cell Biol. 2025;26:15. https://doi.org/10.1186/s12860-025-00539-7
Taraballi F, Pastò A, Bauza G. Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective. 2019;4:100017.
Müller L, Tunger A, Wobus M. Immunomodulatory properties of mesenchymal stromal cells: An update. Front Cell Dev Biol. 2021;9:637725.
Banche-Niclot F, Lim J, McCulloch P, Corradetti B, Taraballi F. Mesenchymal stromal cell immunomodulatory potential for orthopedic applications can be fine-tuned via 3D nano-engineered scaffolds. 2024:1–12.
Van der Valk J, Bieback K, Buta C. Fetal bovine serum (FBS): Past–present–future. Altex. 2018;35(1):1–20.
Lee JY, Kang MH, Jang JE. Comparative analysis of mesenchymal stem cells cultivated in serum free media. Sci Rep. 2022;12:8620. https://doi.org/10.1038/s41598-022-12467-z
Borger A, Haertinger M, Millesi F. Conditioning period impacts the morphology and proliferative effect of extracellular vesicles derived from rat adipose tissue derived stromal cells. J Nanobiotechnol. 2025;23:164. https://doi.org/10.1186/s12951-025-03273-6
Delabie W, Vandewalle V, Seghers S. Comparison of culture media supplements identifies serum components in self-reported serum-free preparations. Stem Cell Res Ther. 2025;16:454. https://doi.org/10.1186/s13287-025-04561-6
Hoang VT, Trinh QM, Phuong DTM. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources. Cytotherapy. 2021;23(1):88–99.
Aussel C, Busson E, Vantomme H. Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells. PeerJ. 2022;10:e13391.
Palombella S, Perucca Orfei C, Castellini G. Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: Comparison with fetal bovine serum and considerations on the production protocol. Stem Cell Res Ther. 2022;13(1):142.
Duarte Rojas JM, Restrepo Múnera LM, Estrada Mira S. Comparison between platelet lysate, platelet lysate serum, and fetal bovine serum as supplements for cell culture, expansion, and cryopreservation. Biomedicines. 2024;12(1).
Lensch M, Muise A, White L, Badowski M, Harris D. Comparison of synthetic media designed for expansion of adipose-derived mesenchymal stromal cells. Biomedicines. 2018;6(2).
Copyright (c) 2025 International Journal of Cell and Biomedical Science
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
